- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.1: 9 residues within 4Å:- Chain A: S.211, P.214, V.256, L.263, N.264, G.380, V.446, S.447
- Ligands: NAG-NAG.2
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.380
NAG-NAG-BMA-MAN-MAN.10: 8 residues within 4Å:- Chain C: H.68, V.256, L.263, N.264, C.445, V.446, S.447
- Ligands: NAG-NAG.11
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.380
NAG-NAG-BMA-MAN-MAN.18: 8 residues within 4Å:- Chain E: E.213, V.256, L.263, N.264, G.380, V.446, S.447
- Ligands: NAG-NAG.19
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:G.380
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 6 residues within 4Å:- Chain A: S.293, Q.295, V.446, S.447, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN.1
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 4 residues within 4Å:- Chain A: S.152, F.153, N.154, K.165
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 4 residues within 4Å:- Chain A: N.297, N.333, V.334, V.446
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 5 residues within 4Å:- Chain A: R.194, I.196, N.199, T.200
- Chain C: R.310
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.196
NAG-NAG.6: 4 residues within 4Å:- Chain A: N.150, Y.167, G.321, D.322
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.167
NAG-NAG.7: 4 residues within 4Å:- Chain A: N.303, I.324, G.441, V.442
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 3 residues within 4Å:- Chain A: H.87, N.243, V.244
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 6 residues within 4Å:- Chain A: N.297, T.299, H.331, N.333, S.413, T.415
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 4 residues within 4Å:- Chain C: N.264, Q.295, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN.10
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 3 residues within 4Å:- Chain C: S.152, F.153, N.154
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 6 residues within 4Å:- Chain C: Q.295, N.297, N.333, V.334, S.335, R.444
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 5 residues within 4Å:- Chain C: R.194, I.196, N.199, T.200
- Chain E: R.310
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:I.196
NAG-NAG.15: 4 residues within 4Å:- Chain C: N.138, N.150, Y.167, D.322
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.167
NAG-NAG.16: 7 residues within 4Å:- Chain C: N.297, T.299, H.331, N.333, S.413, T.415, R.444
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 3 residues within 4Å:- Chain C: S.389, G.390, N.393
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 4 residues within 4Å:- Chain E: N.264, S.293, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN.18
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 2 residues within 4Å:- Chain E: Q.132, N.154
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 4 residues within 4Å:- Chain E: Q.295, N.297, N.333
- Ligands: NAG-NAG.27
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 4 residues within 4Å:- Chain A: R.310
- Chain E: R.194, N.199, T.200
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 2 residues within 4Å:- Chain E: N.303, V.442
No protein-ligand interaction detected (PLIP)NAG-NAG.25: 4 residues within 4Å:- Chain E: E.89, N.90
- Chain F: G.8, S.9
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 5 residues within 4Å:- Chain E: H.87, L.88, K.233, N.243, V.244
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 6 residues within 4Å:- Chain E: N.297, T.299, N.333, T.415, R.444
- Ligands: NAG-NAG.21
No protein-ligand interaction detected (PLIP)NAG-NAG.28: 5 residues within 4Å:- Chain E: N.135, G.146, R.172
- Chain H: X.86, X.87
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.23: 5 residues within 4Å:- Chain E: N.150, Y.167, L.169
- Chain G: X.97
- Ligands: NAG.62
No protein-ligand interaction detected (PLIP)- 37 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.29: 3 residues within 4Å:- Chain A: N.278, T.280, N.281
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain A: T.373, T.374, N.387, S.389
- Ligands: NAG.31
Ligand excluded by PLIPNAG.31: 6 residues within 4Å:- Chain A: N.364, S.365, S.366, G.367, T.373
- Ligands: NAG.30
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: N.236, T.238, S.276
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: N.135, G.146
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain A: E.89, N.90
- Chain B: G.8, S.9
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: E.271, N.291, E.292
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: K.336, N.340, W.396
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: R.351, N.356
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain A: S.389, N.393
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: K.114, E.115, N.118
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: N.92, S.94
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain C: N.278, I.279, T.280, N.281
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.387, S.389
- Ligands: NAG.43
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain C: N.364, S.365, S.366, T.373
- Ligands: NAG.42
Ligand excluded by PLIPNAG.44: 5 residues within 4Å:- Chain C: W.98, N.236, T.238, S.276, I.279
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.135
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: N.303, I.324, V.442
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain C: E.89, N.90
- Chain D: G.8, S.9
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: H.87, K.231, N.243, V.244
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain C: E.270, E.271, N.291, E.292
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: N.340, W.396
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.356
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain D: N.118, Y.119
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain D: N.92, S.94
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain E: N.278, I.279, T.280
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain E: T.373, N.387, S.389
- Ligands: NAG.56
Ligand excluded by PLIPNAG.56: 5 residues within 4Å:- Chain E: N.364, S.365, S.366, T.373
- Ligands: NAG.55
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain E: N.236, T.238, S.276, I.279
Ligand excluded by PLIPNAG.58: 6 residues within 4Å:- Chain E: E.270, E.271, V.272, N.291, E.292, K.345
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain E: K.336, N.340, W.396
Ligand excluded by PLIPNAG.60: 1 residues within 4Å:- Chain E: N.356
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain E: N.393
Ligand excluded by PLIPNAG.62: 6 residues within 4Å:- Chain E: V.136, N.138, N.139, I.323
- Chain G: X.96
- Ligands: NAG-NAG-BMA.23
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain F: E.115, S.117, N.118
Ligand excluded by PLIPNAG.64: 2 residues within 4Å:- Chain F: N.99, S.101
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain F: P.90, N.92, S.94
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP.v5.2(7S) - gp120: ACE
BG505 SOSIP.v5.2(7S) - gp41: BDF
Rh.33172 pAbC-4 - Heavy Chain: G
Rh.33172 pAbC-4 - Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CC
EE
AB
DD
FF
BG
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 37 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP.v5.2(7S) - gp120: ACE
BG505 SOSIP.v5.2(7S) - gp41: BDF
Rh.33172 pAbC-4 - Heavy Chain: G
Rh.33172 pAbC-4 - Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CC
EE
AB
DD
FF
BG
HH
L